Health Care Biogen walks away from controversial Alzheimer’s drug Aduhelm Health Care / 9 months ago by Nathaniel Weixel 01/31/24 2:42 PM ET
Health Care FDA approves first Alzheimer’s therapy shown to slow cognitive decline Health Care / 1 year ago by Nathaniel Weixel 07/06/23 5:16 PM ET
Health Care Medicare won’t change coverage policy for pricey Alzheimer’s drugs Health Care / 1 year ago by Nathaniel Weixel 06/01/23 11:59 AM ET
Health Care Biogen halves price of controversial Alzheimer’s drug Health Care / 3 years ago by Nathaniel Weixel 12/20/21 10:48 AM ET
Health Care Biogen investigating death of patient taking Alzheimer’s drug Health Care / 3 years ago by Nathaniel Weixel 11/10/21 4:16 PM ET
Administration Sales of new Alzheimer’s drug fall short of expectations Administration / 3 years ago by Justine Coleman 10/21/21 10:30 AM ET
Healthcare FDA’s accelerated approval process is good enough for cancer and AIDS. Why not Alzheimer’s? Healthcare / 3 years ago by George Vradenburg, opinion contributor 09/22/21 2:30 PM ET
Health Care Overnight Health Care: Democrats plot response to Texas abortion law Health Care / 3 years ago by Nathaniel Weixel,Peter Sullivan and Justine Coleman 09/02/21 6:00 PM ET
Health Care House Democrats ramp up probe of FDA approval of Alzheimer’s drug Health Care / 3 years ago by Nathaniel Weixel 09/02/21 1:33 PM ET
Health Care Cleveland Clinic, Mount Sinai not administering new Alzheimer’s drug Health Care / 3 years ago by Justine Coleman 07/15/21 10:47 AM ET
Senate Biogen opens door to adjusting price of Alzheimer’s drug amid outcry Senate / 3 years ago by Peter Sullivan 06/23/21 1:58 PM ET
Health Care Former FDA adviser: ‘No good evidence’ that approved Alzheimer’s treatment works Health Care / 3 years ago by Joseph Choi 06/21/21 4:01 PM ET
State Watch Boston conference in February linked to as many as 300,000 coronavirus cases worldwide State Watch / 4 years ago by Morgan Gstalter 12/11/20 8:41 AM ET
